| European consensus conference on faecal microbiota transplantation in clinical practice G Cammarota, G Ianiro, H Tilg, M Rajilić-Stojanović, P Kump, R Satokari, ... Gut 66 (4), 569-580, 2017 | 1101 | 2017 |
| The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of … BH Mullish, MN Quraishi, JP Segal, VL McCune, M Baxter, GL Marsden, ... Gut 67 (11), 1920-1941, 2018 | 355 | 2018 |
| The gut virome: the ‘missing link’between gut bacteria and host immunity? I Mukhopadhya, JP Segal, SR Carding, AL Hart, GL Hold Therapeutic advances in gastroenterology 12, 1756284819836620, 2019 | 170 | 2019 |
| Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic G Ianiro, BH Mullish, CR Kelly, Z Kassam, EJ Kuijper, SC Ng, TH Iqbal, ... Gut 69 (9), 1555-1563, 2020 | 142 | 2020 |
| Ulcerative colitis: an update JP Segal, JF LeBlanc, AL Hart Clinical Medicine 21 (2), 135, 2021 | 139 | 2021 |
| SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group … JL Alexander, GW Moran, DR Gaya, T Raine, A Hart, NA Kennedy, ... The Lancet Gastroenterology & Hepatology 6 (3), 218-224, 2021 | 118 | 2021 |
| Systematic review with meta‐analysis: the management of chronic refractory pouchitis with an evidence‐based treatment algorithm JP Segal, NS Ding, G Worley, S Mclaughlin, S Preston, OD Faiz, SK Clark, ... Alimentary Pharmacology & Therapeutics 45 (5), 581-592, 2017 | 112 | 2017 |
| Bacteroides thetaiotaomicron-derived outer membrane vesicles promote regulatory dendritic cell responses in health but not in inflammatory bowel disease L Durant, R Stentz, A Noble, J Brooks, N Gicheva, D Reddi, MJ O’Connor, ... Microbiome 8, 1-16, 2020 | 86 | 2020 |
| Diagnosis and classification of ileal pouch disorders: consensus guidelines from the International Ileal Pouch Consortium B Shen, GS Kochhar, R Kariv, X Liu, U Navaneethan, DT Rubin, RK Cross, ... The lancet Gastroenterology & hepatology 6 (10), 826-849, 2021 | 85 | 2021 |
| The gut microbiome: an under-recognised contributor to the COVID-19 pandemic? JP Segal, JWY Mak, BH Mullish, JL Alexander, SC Ng, JR Marchesi Therapeutic Advances in Gastroenterology 13, 1756284820974914, 2020 | 79 | 2020 |
| Deficient resident memory T cell and CD8 T cell response to commensals in inflammatory bowel disease A Noble, L Durant, L Hoyles, AL McCartney, R Man, J Segal, SP Costello, ... Journal of Crohn's and Colitis 14 (4), 525-537, 2020 | 65 | 2020 |
| The application of omics techniques to understand the role of the gut microbiota in inflammatory bowel disease JP Segal, BH Mullish, MN Quraishi, A Acharjee, HRT Williams, T Iqbal, ... Therapeutic advances in gastroenterology 12, 1756284818822250, 2019 | 62 | 2019 |
| Vitamin D therapy in adults with inflammatory bowel disease: a systematic review and meta-analysis Y Guzman-Prado, O Samson, JP Segal, JK Limdi, BH Hayee Inflammatory bowel diseases 26 (12), 1819-1830, 2020 | 60 | 2020 |
| COVID-19 as a trigger of irritable bowel syndrome: A review of potential mechanisms CR Settanni, G Ianiro, FR Ponziani, S Bibbò, JP Segal, G Cammarota, ... World Journal of Gastroenterology 27 (43), 7433, 2021 | 55 | 2021 |
| Treatment of pouchitis, Crohn's disease, cuffitis, and other inflammatory disorders of the pouch: consensus guidelines from the International Ileal Pouch Consortium B Shen, GS Kochhar, DT Rubin, SV Kane, U Navaneethan, CN Bernstein, ... The Lancet Gastroenterology & Hepatology 7 (1), 69-95, 2022 | 54 | 2022 |
| Systematic review: ileoanal pouch microbiota in health and disease JP Segal, S Oke, GL Hold, SK Clark, OD Faiz, AL Hart Alimentary Pharmacology & Therapeutics 47 (4), 466-477, 2018 | 41 | 2018 |
| Efficacy of oral, topical, or combined oral and topical 5-aminosalicylates, in ulcerative colitis: systematic review and network meta-analysis B Barberio, JP Segal, MN Quraishi, CJ Black, EV Savarino, AC Ford Journal of Crohn's and Colitis 15 (7), 1184-1196, 2021 | 35 | 2021 |
| The microbiome as a therapy in pouchitis and ulcerative colitis JF LeBlanc, JP Segal, LM de Campos Braz, AL Hart Nutrients 13 (6), 1780, 2021 | 30 | 2021 |
| Current practices in ileal pouch surveillance for patients with ulcerative colitis: a multinational, retrospective cohort study MA Samaan, K Forsyth, JP Segal, D De Jong, JLA Vleugels, S Elkady, ... Journal of Crohn's and Colitis 13 (6), 735-743, 2019 | 30 | 2019 |
| Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study S Sebastian, GJ Walker, NA Kennedy, TE Conley, KV Patel, ... The Lancet Gastroenterology & Hepatology 6 (4), 271-281, 2021 | 29 | 2021 |
Mohammed Nabil QuraishiSheikh Shakhbout Medical City and University of Birmingham Microbiome Treatment CentreVerified email at bham.ac.uk
